Diamyd Medical receives SEK 15 million in a direct issue
Diamyd Medical (Nasdaq Stockholm First North Ticker: DMYD B) informs that the Company has accepted an offer from a group of international institutional investors, previously not shareholders in Diamyd Medical, to issue 2,000,000 new B shares in a direct placement at 7.50 SEK per share. Total proceeds to the Company amount to SEK 15 million.“This new capital to Diamyd Medical is welcome and will allow us to focus more on partnership,” says Anders Essen-Möller, President and CEO of Diamyd Medical. After registration of the new issue, the number of shares in Diamyd Medical will amount to 21,